BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11876395)

  • 21. Possible risk factors associated with radiation proctitis or radiation cystitis in patients with cervical carcinoma after radiotherapy.
    Yang L; Lv Y
    Asian Pac J Cancer Prev; 2012; 13(12):6251-5. PubMed ID: 23464440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Shiau AC; Yu CY; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    J Radiat Res; 2010; 51(2):173-9. PubMed ID: 20339254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix.
    Pedersen D; Bentzen SM; Overgaard J
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):941-52. PubMed ID: 8083095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The irradiation tolerance dose of the proximal vagina.
    Au SP; Grigsby PW
    Radiother Oncol; 2003 Apr; 67(1):77-85. PubMed ID: 12758243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results.
    Lei X; Qian CY; Qing Y; Zhao KW; Yang ZZ; Dai N; Zhong ZY; Tang C; Li Z; Gu XQ; Zhou Q; Feng Y; Xiong YL; Shan JL; Wang D
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1264-70. PubMed ID: 21435797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies.
    Bajwa HK; Singareddy R; Krishnam Raju A
    Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma.
    Rovirosa A; Ascaso C; Sánchez-Reyes A; Herreros A; Abellana R; Pahisa J; Lejarcegui JA; Biete A
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):418-23. PubMed ID: 20800388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
    Chopra S; Dora T; Engineer R; Mechanery S; Agarwal P; Kannan S; Ghadi Y; Swamidas J; Mahantshetty U; Shrivastava SK
    Brachytherapy; 2015; 14(6):881-8. PubMed ID: 26409708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India.
    Saibishkumar EP; Patel FD; Sharma SC
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):30-7. PubMed ID: 16477917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Historical overview and the current practice of intracavitary treatment of cervical and endometrial cancer in the Oncoradiology Center of Budapest].
    Sinkó D; Nemeskéri C; Pallinger Á; Weisz C; Naszály A; Landherr L
    Magy Onkol; 2015 Jun; 59(2):140-7. PubMed ID: 26035162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
    Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.